#SLS009 - Twitter Hashtag

30 days ago

$SLS #Cancer_vax. #leukemia @SellasLife has seen massive gains (hundreds of percent YTD/) #REGAL Phase 3 data is highly anticipated (readout soon). CEO highlighted longer-than-expected patient survival encouraging. #SLS009 is advancing in frontline #AML & other indications.

0

2

1

0

171

Tad Dickson @TadDickson333

about 1 month ago

$SLS Phase 2a Trial: #SLS009 + aza/ven in patients who failed or were refractory to #venetoclax-based therapy. Met primary endpoints. Stronger responses in ASXL1-mutated patients and certain subtypes (e.g., M4/M5). Median OS notably improved vs. historical benchmarks.

$TadDickson333's tweet photo. $SLS Phase 2a Trial: #SLS009 + aza/ven in patients who failed or were refractory to #venetoclax-based therapy. Met primary endpoints. Stronger responses in ASXL1-mutated patients and certain subtypes (e.g., M4/M5). Median OS notably improved vs. historical benchmarks. https://t.co/zYQSYBFbms$

0

3

1

159

Tad Dickson @TadDickson333

about 2 months ago

#GPS 21 MONTHS VS 5 MONTHS. #SLS009 #Leukemia_survival 8 months over 2 months. #Lymph_cancer using a #combo_therapy. @SellasLife #WT1 #1_CANCER_ANTIGEN , $SLS #REMISSION #Saftey_is_favorable. #survival_maintenance_therapy

Steve Jacob

@SteveJacob911

about 2 months ago

$SLS Everyone is focused on the 80th event. I'm focused on what comes after. If GPS demonstrates a strong survival benefit in Phase 3 AML, how many other WT1-positive cancers suddenly become targets? Sometimes the biggest catalyst isn't the data. It's what the data unlocks. 🧬🚀

0

12

1

0

576

0

3

1

0

74

William the Whale 🏘 💵

@Williamthawhale

2 months ago

$SLS Leukemia care relies on intensive chemo, targeted therapy, and stem cell transplants. For elderly patients, high toxicity makes these standard options incredibly difficult to tolerate, leading to poor outcomes. This is where the unmet need lies. #SLS009 #GPS

1

4

0

564

Tad Dickson @TadDickson333

2 months ago

$SLS #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to #leukemia_survival and progression. @SellasLife ended the first quarter with roughly $107.1 million in cash and cash equivalents.

TadDickson333's tweet photo. $SLS #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to #leukemia_survival and progression.
@SellasLife ended the first quarter with roughly $107.1 million in cash and cash equivalents. https://t.co/zYvz8JjEzW

Tad Dickson @TadDickson333

2 months ago

$SLS Recent research presented by Sellas showed #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to leukemia survival and progression. @SellasLife ended the first quarter with roughly $107.1 million in cash and cash equivalents.

1

4

2

0

611

0

3

1

0

435

Tad Dickson @TadDickson333

2 months ago

$SLS. Recent research presented by Sellas showed #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to leukemia survival and progression. @SellasLife. ended the first quarter with roughly $107.1 million in #cash and #cash_equivalents.

TadDickson333's tweet photo. $SLS. Recent research presented by Sellas showed #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to leukemia survival and progression.
@SellasLife. ended the first quarter with roughly $107.1 million in #cash and #cash_equivalents. https://t.co/HIbVYDlcuN

0

9

4

0

1K

Tad Dickson @TadDickson333

2 months ago

$SLS Recent research presented by Sellas showed #SLS009 rapidly triggered #AML_cell_death, while suppressing proteins linked to leukemia survival and progression. @SellasLife ended the first quarter with roughly $107.1 million in cash and cash equivalents.

1

4

2

0

611

Tad Dickson @TadDickson333

4 months ago

$SLS @SellasLife #Stocks #Cancer #vax #basketball Angelos Stergiou highlighted 2026 as pivotal, with the company progressing with its Phase 3 trials and developing new cohorts for #SLS009. SELLAS is viewed as a high-potential volatile small-cap #biotech company

TadDickson333's tweet photo. $SLS @SellasLife #Stocks #Cancer #vax #basketball
Angelos Stergiou highlighted 2026 as pivotal, with the company progressing with its Phase 3 trials and developing new cohorts for #SLS009. SELLAS is viewed as a high-potential volatile small-cap #biotech company https://t.co/eSYEe1oMSS

0

3

2

0

326

Tad Dickson @TadDickson333

4 months ago

$SLS @SellasLife #Stocks #Cancer #vax Angelos Stergiou highlighted 2026 as pivotal, with the company progressing with its Phase 3 trials and developing new cohorts for #SLS009. SELLAS is viewed as a high-potential volatile small-cap #biotech company

TadDickson333's tweet photo. $SLS @SellasLife #Stocks #Cancer #vax
Angelos Stergiou highlighted 2026 as pivotal, with the company progressing with its Phase 3 trials and developing new cohorts for #SLS009. SELLAS is viewed as a high-potential volatile small-cap #biotech company https://t.co/VXCdWn6BHb

0

3

2

1

275

Tad Dickson @TadDickson333

6 months ago

@SellasLife mission emphasizes addressing unmet needs in #oncology through innovative immunotherapies and targeted inhibitors, with a pipeline centered on two lead candidates: #galinpepimut-S (GPS), a WT1-targeted #cancer_immunotherapy, and #SLS009 (tambiciclib). $SLS.

TadDickson333's tweet photo. @SellasLife mission emphasizes addressing unmet needs in #oncology through innovative immunotherapies and targeted inhibitors, with a pipeline centered on two lead candidates: #galinpepimut-S (GPS), a WT1-targeted #cancer_immunotherapy, and #SLS009 (tambiciclib). $SLS. https://t.co/JVYVDW5dkS

0

2

1

0

32

Tad Dickson @TadDickson333

7 months ago

@SellasLife The Market Is Paying Attention Again To $SLS Stock The Emerging Role Of #SLS009 In Broadening The #Pipeline. SELLAS Life Sciences Group (SLS) Just Took a Big Step Toward Changing How Cancer Is Treated • BioTech Health X

0

1

2

0

283

Nasfact @DNasfact

7 months ago

$SLS MASSIVE NEWS! #BULLISH #SLS #Cancer #AML #GPS #SLS009 Patience for the Patience! Buy out 80-150$

2

37

6

2

8K

Tad Dickson @TadDickson333

12 months ago

@SELLAS Life Sciences Reports Second Quarter 2025 Financial Results & Provides Corporate Update. $SLS Phase 2 trial of #SLS009 achieved 44% response rate in AML-MRC, exceeding 20% target Median overall survival of 8.9 months in #AML-MRC patients. https://t.co/FYrw18EvbU

0

2

1

0

142

Tad Dickson @TadDickson333

12 months ago

@SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update. $SLS Phase 2 trial of #SLS009 achieved 44% response rate in AML-MRC, exceeding 20% target Median overall survival of 8.9 months in #AML-MRC patients. https://t.co/FYrw18EvbU

0

2

0

136

Tad Dickson @TadDickson333

over 1 year ago

$SLS @SellasLife #nasdaq #SLS009 #AML #CURECANCER #THEREPY #LOWFLOAT

CEOofstocks 🍁

@CEOofstocks

over 1 year ago

$SLS NEWS! Almost 3x BAT for SLS009 in R/R AML P2 results. This is massive. Combined therapy with GPS which is on the cusp of final P3 results & they have a 1-2 punch worth BILLIONS. I've said this many times, this is a GENERATIONAL opportunity. $XBI #Biotechnology

2

10

1

0

910

0

1

0

198

PRISM MarketView

@PrismMarketView

almost 3 years ago

.@SellasLife SLS009 Phase 1 Clinical Study Successfully Achieves All Primary and Secondary Endpoints https://t.co/9m1S4XUohU @SellasLife Group, Inc. (Nasdaq: $SLS) #sellaslifescience #SLS009 #GenFleetTherapeutics #therapeutics

0

34

4

0

32K

Top Tweets for #SLS009

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users